Pradaxa Recalled for Stroke Risk

Today, Berhringer Ingelheim Pharmaceuticals announced a recall of Pradaxa with an expiration of January 15, 2015. There is a risk of stroke and systemic embolism for those with non-valvular artrial fibrillation. One particular lot number is involved in this recall. A packaging defect resulted in the recall. Moisture might get into a bottle due to a bottling defect, resulting in a reduction in the quality of the 75mg Pradaxa. Patients are told to continue taking the product until they get a replacement. Details about this recall were sent to patients. Those who have not received information are asked to contact the company immediately, according to news reports.

Comments

Comments are disabled for this post